ADA Buffering Agent

• Description:

  ADA Buffering Agent_x000D_ Catalog number: B2015340_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5 g_x000D_ Molecular Weight or Concentration: 190.22 g/mol_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: RT_x000D_ Keywords: MHA; N-(2-acetamido)iminodiacetic acid; N-(carbamoylmethyl)iminodiacetic acid_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Wingert S, Reusch U, Knackmuss S, Kluge M, Damrat M, Pahl J, Schniegler-Mattox U, Mueller T, Fucek I, Ellwanger K, Tesar M, Haneke T, Koch J, Treder M, Fischer W, Rajkovic E. Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors MAbs. 2021 Jan-Dec;13(1):1950264._x000D_ 2: Pakdaman A, Gholizadeh N, Kharazifard MJ, Eshrati M. Clinical practice guideline adaptation for risk-based caries management in 18-55 year-old Iranian adults BMC Oral Health. 2023 Jan 6;23(1):7._x000D_ 3: Jang BS, Park SH, Shin IS, Maeng JS, Paik CH. Biodistribution of (99m)tc labeled integrin antagonist Toxicol Res. 2013 Mar;29(1):21-5._x000D_ 4: Klasen B, Lemcke D, Mindt TL, Gasser G, Rösch F. Development and in vitro evaluation of new bifunctional (89)Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications Nucl Med Biol. 2021 Nov-Dec;102-103:12-23._x000D_ 5: Garner JR, Wajdowicz MN, DuVall NB, Roberts HW. Selected physical properties of new resin-modified glass ionomer luting cements J Prosthet Dent. 2017 Feb;117(2):277-282._x000D_ 6: Szalontay L, Schally AV, Popovics P, Vidaurre I, Krishan A, Zarandi M, Cai RZ, Klukovits A, Block NL, Rick FG. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function Cell Cycle. 2014;13(17):2790-7._x000D_ 7: Nakabeppu Y, Kondo H, Kawabata S, Iwanaga S, Sekiguchi M. Purification and structure of the intact Ada regulatory protein of Escherichia coli K12, O6-methylguanine-DNA methyltransferase J Biol Chem. 1985 Jun 25;260(12):7281-8._x000D_ 8: Terentyev D, Viatchenko-Karpinski S, Valdivia HH, Escobar AL, Györke S. Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes Circ Res. 2002 Sep 6;91(5):414-20._x000D_ 9: Yorganci K, Krepel C, Weigelt JA, Edmiston CE. Activity of antibacterial impregnated central venous catheters against Klebsiella pneumoniae Intensive Care Med. 2002 Apr;28(4):438-42._x000D_ 10: Broekemeier KM, Iben JR, LeVan EG, Crouser ED, Pfeiffer DR. Pore formation and uncoupling initiate a Ca2+-independent degradation of mitochondrial phospholipids Biochemistry. 2002 Jun 18;41(24):7771-80. _x000D_ _x000D_ Products Related to ADA Buffering Agent can be found at Chemicals

• Short Description:

  Catalog Number: B2015340 (5 g)

• Weight:

  0.8

• Length:

  2

• Width:

  0.9

• Height:

  0.9

• Height :

  0.9